Home » FDA Studies Focus on Risk Information in Online Drug Communications
FDA Studies Focus on Risk Information in Online Drug Communications
The FDA is planning studies on whether drugmakers are effectively conveying the risks associated with a drug when benefit claims about the drug are made online in character-space-limited communications.
The research is designed to determine whether a link to the risk information is sufficient and what consumers are looking for when turning to the internet for drug information, according to a Federal Register notice.
What a consumer is looking for can affect what information they pay attention to and what kind of information they find, and as a result the studies will review whether participants are instructed to browse the information or to search for specific information.
Upcoming Events
-
07May
-
14May
-
30May